nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—liver cancer	0.598	1	CbGaD
Pioglitazone—CYP2C8—Sorafenib—liver cancer	0.041	0.237	CbGbCtD
Pioglitazone—CYP2C19—Sorafenib—liver cancer	0.0344	0.199	CbGbCtD
Pioglitazone—CYP2C9—Sorafenib—liver cancer	0.0286	0.166	CbGbCtD
Pioglitazone—CYP2D6—Sorafenib—liver cancer	0.0262	0.151	CbGbCtD
Pioglitazone—CYP3A4—Sorafenib—liver cancer	0.0166	0.0963	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—liver cancer	0.0159	0.0919	CbGbCtD
Pioglitazone—Drug-induced liver injury—Sorafenib—liver cancer	0.0152	0.136	CcSEcCtD
Pioglitazone—CYP3A4—Doxorubicin—liver cancer	0.0101	0.0584	CbGbCtD
Pioglitazone—Ischaemia—Sorafenib—liver cancer	0.00437	0.0392	CcSEcCtD
Pioglitazone—Transient ischaemic attack—Sorafenib—liver cancer	0.00316	0.0283	CcSEcCtD
Pioglitazone—Rosiglitazone—PPARG—liver cancer	0.00268	0.727	CrCbGaD
Pioglitazone—Myocardial ischaemia—Sorafenib—liver cancer	0.00198	0.0178	CcSEcCtD
Pioglitazone—Proteinuria—Sorafenib—liver cancer	0.00181	0.0163	CcSEcCtD
Pioglitazone—Protein urine present—Sorafenib—liver cancer	0.00179	0.016	CcSEcCtD
Pioglitazone—Neoplasm—Sorafenib—liver cancer	0.00144	0.0129	CcSEcCtD
Pioglitazone—Tooth abscess—Epirubicin—liver cancer	0.00141	0.0126	CcSEcCtD
Pioglitazone—Tooth abscess—Doxorubicin—liver cancer	0.00131	0.0117	CcSEcCtD
Pioglitazone—Hepatic failure—Sorafenib—liver cancer	0.00129	0.0115	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Sorafenib—liver cancer	0.00128	0.0114	CcSEcCtD
Pioglitazone—Cardiac failure—Sorafenib—liver cancer	0.00119	0.0106	CcSEcCtD
Pioglitazone—Pain in extremity—Sorafenib—liver cancer	0.00116	0.0104	CcSEcCtD
Pioglitazone—Abdominal pain upper—Sorafenib—liver cancer	0.00106	0.00948	CcSEcCtD
Pioglitazone—Breast disorder—Sorafenib—liver cancer	0.00105	0.00937	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00102	0.00915	CcSEcCtD
Pioglitazone—Rosiglitazone—ALB—liver cancer	0.00101	0.273	CrCbGaD
Pioglitazone—Generalised oedema—Epirubicin—liver cancer	0.000991	0.00888	CcSEcCtD
Pioglitazone—Polyp—Epirubicin—liver cancer	0.000969	0.00868	CcSEcCtD
Pioglitazone—Erectile dysfunction—Sorafenib—liver cancer	0.000921	0.00826	CcSEcCtD
Pioglitazone—Generalised oedema—Doxorubicin—liver cancer	0.000917	0.00822	CcSEcCtD
Pioglitazone—Weight decreased—Sorafenib—liver cancer	0.000905	0.00811	CcSEcCtD
Pioglitazone—Polyp—Doxorubicin—liver cancer	0.000896	0.00803	CcSEcCtD
Pioglitazone—Infestation—Sorafenib—liver cancer	0.000892	0.00799	CcSEcCtD
Pioglitazone—Infestation NOS—Sorafenib—liver cancer	0.000892	0.00799	CcSEcCtD
Pioglitazone—Cyst—Epirubicin—liver cancer	0.000882	0.0079	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Sorafenib—liver cancer	0.000879	0.00788	CcSEcCtD
Pioglitazone—Myocardial infarction—Sorafenib—liver cancer	0.000874	0.00784	CcSEcCtD
Pioglitazone—Cyst—Doxorubicin—liver cancer	0.000816	0.00731	CcSEcCtD
Pioglitazone—Urinary tract disorder—Sorafenib—liver cancer	0.000791	0.00709	CcSEcCtD
Pioglitazone—Connective tissue disorder—Sorafenib—liver cancer	0.000787	0.00705	CcSEcCtD
Pioglitazone—Urethral disorder—Sorafenib—liver cancer	0.000785	0.00704	CcSEcCtD
Pioglitazone—Cardiac disorder—Sorafenib—liver cancer	0.000743	0.00666	CcSEcCtD
Pioglitazone—Glycosuria—Epirubicin—liver cancer	0.000727	0.00652	CcSEcCtD
Pioglitazone—Immune system disorder—Sorafenib—liver cancer	0.000723	0.00648	CcSEcCtD
Pioglitazone—Mediastinal disorder—Sorafenib—liver cancer	0.000722	0.00647	CcSEcCtD
Pioglitazone—Malnutrition—Sorafenib—liver cancer	0.000697	0.00625	CcSEcCtD
Pioglitazone—Glycosuria—Doxorubicin—liver cancer	0.000673	0.00603	CcSEcCtD
Pioglitazone—Muscle spasms—Sorafenib—liver cancer	0.00067	0.00601	CcSEcCtD
Pioglitazone—Anaemia—Sorafenib—liver cancer	0.000644	0.00577	CcSEcCtD
Pioglitazone—Angioedema—Sorafenib—liver cancer	0.000637	0.00571	CcSEcCtD
Pioglitazone—Hypertension—Sorafenib—liver cancer	0.000602	0.00539	CcSEcCtD
Pioglitazone—Arthralgia—Sorafenib—liver cancer	0.000593	0.00532	CcSEcCtD
Pioglitazone—Myalgia—Sorafenib—liver cancer	0.000593	0.00532	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000589	0.00528	CcSEcCtD
Pioglitazone—Anaphylactic shock—Sorafenib—liver cancer	0.000569	0.0051	CcSEcCtD
Pioglitazone—Infection—Sorafenib—liver cancer	0.000565	0.00507	CcSEcCtD
Pioglitazone—Fluid retention—Epirubicin—liver cancer	0.000559	0.00501	CcSEcCtD
Pioglitazone—Nervous system disorder—Sorafenib—liver cancer	0.000558	0.005	CcSEcCtD
Pioglitazone—Skin disorder—Sorafenib—liver cancer	0.000553	0.00495	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Epirubicin—liver cancer	0.000541	0.00485	CcSEcCtD
Pioglitazone—Neoplasm—Epirubicin—liver cancer	0.000533	0.00478	CcSEcCtD
Pioglitazone—Pulmonary oedema—Epirubicin—liver cancer	0.000525	0.0047	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000518	0.00465	CcSEcCtD
Pioglitazone—Fluid retention—Doxorubicin—liver cancer	0.000518	0.00464	CcSEcCtD
Pioglitazone—Abnormal vision—Epirubicin—liver cancer	0.000514	0.00461	CcSEcCtD
Pioglitazone—Dyspnoea—Sorafenib—liver cancer	0.000507	0.00455	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Doxorubicin—liver cancer	0.000501	0.00449	CcSEcCtD
Pioglitazone—Neoplasm—Doxorubicin—liver cancer	0.000493	0.00442	CcSEcCtD
Pioglitazone—Diabetes mellitus—Epirubicin—liver cancer	0.000492	0.00441	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Sorafenib—liver cancer	0.000491	0.0044	CcSEcCtD
Pioglitazone—Fatigue—Sorafenib—liver cancer	0.00049	0.0044	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—liver cancer	0.000485	0.00435	CcSEcCtD
Pioglitazone—Hepatic failure—Epirubicin—liver cancer	0.000476	0.00427	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—liver cancer	0.000476	0.00426	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Epirubicin—liver cancer	0.000472	0.00423	CcSEcCtD
Pioglitazone—Increased appetite—Epirubicin—liver cancer	0.000455	0.00408	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—liver cancer	0.000455	0.00408	CcSEcCtD
Pioglitazone—Urticaria—Sorafenib—liver cancer	0.000452	0.00405	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—liver cancer	0.00044	0.00395	CcSEcCtD
Pioglitazone—Cardiac failure—Epirubicin—liver cancer	0.000438	0.00393	CcSEcCtD
Pioglitazone—Hypoglycaemia—Epirubicin—liver cancer	0.000438	0.00393	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Epirubicin—liver cancer	0.000437	0.00391	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—liver cancer	0.000436	0.00391	CcSEcCtD
Pioglitazone—Pain in extremity—Epirubicin—liver cancer	0.000428	0.00383	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—liver cancer	0.000421	0.00378	CcSEcCtD
Pioglitazone—Hypersensitivity—Sorafenib—liver cancer	0.000419	0.00376	CcSEcCtD
Pioglitazone—Asthenia—Sorafenib—liver cancer	0.000408	0.00366	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—liver cancer	0.000406	0.00364	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—liver cancer	0.000406	0.00364	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—liver cancer	0.000404	0.00362	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—liver cancer	0.000396	0.00355	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—liver cancer	0.000395	0.00354	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—liver cancer	0.000391	0.0035	CcSEcCtD
Pioglitazone—Diarrhoea—Sorafenib—liver cancer	0.000389	0.00349	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—liver cancer	0.000387	0.00346	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000377	0.00338	CcSEcCtD
Pioglitazone—Dizziness—Sorafenib—liver cancer	0.000376	0.00337	CcSEcCtD
Pioglitazone—Influenza—Epirubicin—liver cancer	0.00037	0.00331	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—liver cancer	0.000365	0.00328	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—liver cancer	0.000362	0.00324	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—liver cancer	0.00036	0.00323	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—liver cancer	0.000358	0.00321	CcSEcCtD
Pioglitazone—Headache—Sorafenib—liver cancer	0.000356	0.00319	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—liver cancer	0.000356	0.00319	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000349	0.00313	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—liver cancer	0.000344	0.00308	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—liver cancer	0.000342	0.00307	CcSEcCtD
Pioglitazone—Weight increased—Epirubicin—liver cancer	0.000336	0.00302	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—liver cancer	0.000334	0.003	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—liver cancer	0.000334	0.00299	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—liver cancer	0.000333	0.00299	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—liver cancer	0.00033	0.00295	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—liver cancer	0.00033	0.00295	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—liver cancer	0.000329	0.00295	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—liver cancer	0.00032	0.00287	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000318	0.00285	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—liver cancer	0.000316	0.00283	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—liver cancer	0.000314	0.00282	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—liver cancer	0.000311	0.00279	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—liver cancer	0.000309	0.00277	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—liver cancer	0.000309	0.00277	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—liver cancer	0.000309	0.00277	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—liver cancer	0.000305	0.00273	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—liver cancer	0.000305	0.00273	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—liver cancer	0.000296	0.00266	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—liver cancer	0.000296	0.00265	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—liver cancer	0.000294	0.00264	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—liver cancer	0.000294	0.00263	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—liver cancer	0.000292	0.00262	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—liver cancer	0.000292	0.00262	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—liver cancer	0.000292	0.00261	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—liver cancer	0.000291	0.00261	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—liver cancer	0.000291	0.00261	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—liver cancer	0.00029	0.0026	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—liver cancer	0.000286	0.00256	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—liver cancer	0.000285	0.00256	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—liver cancer	0.000277	0.00248	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—liver cancer	0.000275	0.00246	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—liver cancer	0.000274	0.00245	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—liver cancer	0.000272	0.00244	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—liver cancer	0.000272	0.00244	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—liver cancer	0.00027	0.00242	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—liver cancer	0.00027	0.00242	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—liver cancer	0.000269	0.00241	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—liver cancer	0.000268	0.00241	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—liver cancer	0.000267	0.0024	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—liver cancer	0.000267	0.00239	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—liver cancer	0.000264	0.00237	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—liver cancer	0.000258	0.00231	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—liver cancer	0.000256	0.00229	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—liver cancer	0.000254	0.00228	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—liver cancer	0.000254	0.00228	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—liver cancer	0.000249	0.00223	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—liver cancer	0.000248	0.00222	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—liver cancer	0.000247	0.00222	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—liver cancer	0.000247	0.00221	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—liver cancer	0.000239	0.00214	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—liver cancer	0.000238	0.00214	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—liver cancer	0.000238	0.00213	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—liver cancer	0.000235	0.00211	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—liver cancer	0.000232	0.00208	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—liver cancer	0.000231	0.00207	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—liver cancer	0.000231	0.00207	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—liver cancer	0.000229	0.00205	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—liver cancer	0.000222	0.00199	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—liver cancer	0.000221	0.00198	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—liver cancer	0.00022	0.00197	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—liver cancer	0.000219	0.00197	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—liver cancer	0.000219	0.00197	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—liver cancer	0.000219	0.00197	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000218	0.00195	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—liver cancer	0.000217	0.00194	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—liver cancer	0.000215	0.00193	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—liver cancer	0.000214	0.00192	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—liver cancer	0.00021	0.00188	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—liver cancer	0.00021	0.00188	CcSEcCtD
Pioglitazone—Infection—Epirubicin—liver cancer	0.000209	0.00187	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—liver cancer	0.000206	0.00185	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—liver cancer	0.000206	0.00184	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—liver cancer	0.000204	0.00183	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—liver cancer	0.000203	0.00182	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—liver cancer	0.000203	0.00182	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—liver cancer	0.000203	0.00182	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—liver cancer	0.000203	0.00182	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000202	0.00181	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—liver cancer	0.000201	0.0018	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—liver cancer	0.000195	0.00174	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—liver cancer	0.000195	0.00174	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—liver cancer	0.000193	0.00173	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000192	0.00172	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—liver cancer	0.000191	0.00171	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—liver cancer	0.00019	0.0017	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—liver cancer	0.000189	0.00169	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—liver cancer	0.000188	0.00169	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—liver cancer	0.000187	0.00168	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000182	0.00163	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—liver cancer	0.000181	0.00162	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000177	0.00159	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—liver cancer	0.000176	0.00158	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—liver cancer	0.000173	0.00155	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—liver cancer	0.000173	0.00155	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000168	0.00151	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—liver cancer	0.000168	0.0015	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—liver cancer	0.000167	0.0015	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—liver cancer	0.00016	0.00144	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—liver cancer	0.000155	0.00139	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—liver cancer	0.000155	0.00139	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—liver cancer	0.000151	0.00135	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—liver cancer	0.000144	0.00129	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—liver cancer	0.000143	0.00128	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—liver cancer	0.00014	0.00125	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—liver cancer	0.000139	0.00125	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—liver cancer	0.000133	0.00119	CcSEcCtD
Pioglitazone—Headache—Epirubicin—liver cancer	0.000132	0.00118	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—liver cancer	0.000129	0.00115	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—liver cancer	0.000122	0.00109	CcSEcCtD
Pioglitazone—SLCO1B3—Metabolism—PPARA—liver cancer	2.29e-05	0.000201	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CPT1B—liver cancer	2.29e-05	0.000201	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GLUL—liver cancer	2.29e-05	0.000201	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.29e-05	0.000201	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PSMA4—liver cancer	2.28e-05	0.0002	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PSMD10—liver cancer	2.28e-05	0.0002	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ESR1—liver cancer	2.28e-05	0.0002	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—UGDH—liver cancer	2.27e-05	0.000199	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.27e-05	0.000199	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.26e-05	0.000198	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTM1—liver cancer	2.26e-05	0.000198	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTA4—liver cancer	2.22e-05	0.000195	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GOT2—liver cancer	2.22e-05	0.000195	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	2.21e-05	0.000194	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NR1H4—liver cancer	2.21e-05	0.000194	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYCS—liver cancer	2.19e-05	0.000192	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.17e-05	0.000191	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTA3—liver cancer	2.17e-05	0.00019	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTA2—liver cancer	2.17e-05	0.00019	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TNF—liver cancer	2.16e-05	0.000189	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GGT1—liver cancer	2.15e-05	0.000189	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GOT1—liver cancer	2.15e-05	0.000189	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—KRAS—liver cancer	2.14e-05	0.000188	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP1A1—liver cancer	2.14e-05	0.000188	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—EPT1—liver cancer	2.14e-05	0.000187	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GLUL—liver cancer	2.11e-05	0.000185	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CPT1B—liver cancer	2.11e-05	0.000185	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTA1—liver cancer	2.09e-05	0.000183	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CPT1B—liver cancer	2.09e-05	0.000183	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GLUL—liver cancer	2.09e-05	0.000183	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP2E1—liver cancer	2.09e-05	0.000183	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NAT2—liver cancer	2.07e-05	0.000181	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.06e-05	0.000181	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NR1H4—liver cancer	2.03e-05	0.000178	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TAT—liver cancer	2.03e-05	0.000178	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.02e-05	0.000177	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NR1H4—liver cancer	2.01e-05	0.000177	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTA3—liver cancer	2e-05	0.000175	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—MTHFR—liver cancer	1.99e-05	0.000175	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.99e-05	0.000174	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTA4—liver cancer	1.99e-05	0.000174	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALDOB—liver cancer	1.98e-05	0.000174	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTA3—liver cancer	1.98e-05	0.000174	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CG—liver cancer	1.96e-05	0.000172	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PPARA—liver cancer	1.96e-05	0.000172	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYCS—liver cancer	1.95e-05	0.000171	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.94e-05	0.00017	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTA2—liver cancer	1.93e-05	0.00017	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTP1—liver cancer	1.93e-05	0.00017	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GGT1—liver cancer	1.92e-05	0.000168	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GOT1—liver cancer	1.92e-05	0.000168	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—HMOX1—liver cancer	1.91e-05	0.000167	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PPARG—liver cancer	1.9e-05	0.000166	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CRABP1—liver cancer	1.89e-05	0.000166	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—SERPINE1—liver cancer	1.87e-05	0.000164	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTA1—liver cancer	1.87e-05	0.000164	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NAT2—liver cancer	1.85e-05	0.000162	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTA4—liver cancer	1.83e-05	0.00016	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—HRAS—liver cancer	1.82e-05	0.00016	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTA4—liver cancer	1.81e-05	0.000159	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTA2—liver cancer	1.78e-05	0.000156	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTM1—liver cancer	1.78e-05	0.000156	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.77e-05	0.000156	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALDOB—liver cancer	1.77e-05	0.000155	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.77e-05	0.000155	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTA2—liver cancer	1.76e-05	0.000155	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.76e-05	0.000154	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—liver cancer	1.74e-05	0.000153	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CD—liver cancer	1.73e-05	0.000151	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTP1—liver cancer	1.72e-05	0.000151	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTA1—liver cancer	1.72e-05	0.000151	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALB—liver cancer	1.7e-05	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.7e-05	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTA1—liver cancer	1.7e-05	0.000149	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NAT2—liver cancer	1.7e-05	0.000149	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—HMOX1—liver cancer	1.7e-05	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CRABP1—liver cancer	1.69e-05	0.000148	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1A1—liver cancer	1.68e-05	0.000148	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NAT2—liver cancer	1.68e-05	0.000148	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CG—liver cancer	1.68e-05	0.000147	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HPGDS—liver cancer	1.65e-05	0.000145	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.64e-05	0.000144	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALDOB—liver cancer	1.63e-05	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.62e-05	0.000142	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALDOB—liver cancer	1.61e-05	0.000142	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—liver cancer	1.61e-05	0.000141	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTM1—liver cancer	1.58e-05	0.000139	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—MTHFR—liver cancer	1.57e-05	0.000138	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CRABP1—liver cancer	1.55e-05	0.000136	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARA—liver cancer	1.54e-05	0.000135	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CRABP1—liver cancer	1.54e-05	0.000135	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.52e-05	0.000133	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CB—liver cancer	1.5e-05	0.000132	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1A1—liver cancer	1.5e-05	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.5e-05	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.48e-05	0.00013	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HPGDS—liver cancer	1.48e-05	0.000129	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PSMA4—liver cancer	1.47e-05	0.000129	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PSMD10—liver cancer	1.47e-05	0.000129	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CD—liver cancer	1.47e-05	0.000129	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.47e-05	0.000129	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—liver cancer	1.45e-05	0.000128	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GOT2—liver cancer	1.43e-05	0.000126	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MTHFR—liver cancer	1.4e-05	0.000123	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.39e-05	0.000122	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.38e-05	0.000121	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GLUL—liver cancer	1.38e-05	0.000121	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CPT1B—liver cancer	1.38e-05	0.000121	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARA—liver cancer	1.37e-05	0.00012	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HPGDS—liver cancer	1.36e-05	0.000119	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP2E1—liver cancer	1.35e-05	0.000118	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HPGDS—liver cancer	1.35e-05	0.000118	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.34e-05	0.000117	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.34e-05	0.000117	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NR1H4—liver cancer	1.33e-05	0.000116	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CG—liver cancer	1.32e-05	0.000116	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.32e-05	0.000116	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMD10—liver cancer	1.31e-05	0.000115	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMA4—liver cancer	1.31e-05	0.000115	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA3—liver cancer	1.31e-05	0.000114	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.3e-05	0.000114	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CB—liver cancer	1.28e-05	0.000113	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GOT2—liver cancer	1.28e-05	0.000112	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—liver cancer	1.27e-05	0.000112	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYCS—liver cancer	1.26e-05	0.000111	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GOT1—liver cancer	1.24e-05	0.000109	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GGT1—liver cancer	1.24e-05	0.000109	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.23e-05	0.000108	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.22e-05	0.000107	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMA4—liver cancer	1.21e-05	0.000106	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMD10—liver cancer	1.21e-05	0.000106	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP2E1—liver cancer	1.2e-05	0.000105	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.2e-05	0.000105	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMA4—liver cancer	1.2e-05	0.000105	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMD10—liver cancer	1.2e-05	0.000105	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA4—liver cancer	1.19e-05	0.000105	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—liver cancer	1.19e-05	0.000104	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GOT2—liver cancer	1.18e-05	0.000103	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—liver cancer	1.17e-05	0.000103	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GOT2—liver cancer	1.17e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.16e-05	0.000102	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA2—liver cancer	1.16e-05	0.000102	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CD—liver cancer	1.16e-05	0.000102	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—liver cancer	1.15e-05	0.0001	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—liver cancer	1.13e-05	9.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYCS—liver cancer	1.13e-05	9.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA1—liver cancer	1.12e-05	9.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—liver cancer	1.11e-05	9.75e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NAT2—liver cancer	1.11e-05	9.73e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2E1—liver cancer	1.11e-05	9.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GOT1—liver cancer	1.1e-05	9.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GGT1—liver cancer	1.1e-05	9.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2E1—liver cancer	1.1e-05	9.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMOX1—liver cancer	1.1e-05	9.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDOB—liver cancer	1.06e-05	9.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.06e-05	9.31e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYCS—liver cancer	1.03e-05	9.08e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CD—liver cancer	1.03e-05	9.05e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYCS—liver cancer	1.03e-05	9e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—liver cancer	1.02e-05	8.96e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—liver cancer	1.02e-05	8.94e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GGT1—liver cancer	1.02e-05	8.91e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GOT1—liver cancer	1.02e-05	8.91e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CRABP1—liver cancer	1.01e-05	8.9e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CB—liver cancer	1.01e-05	8.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GGT1—liver cancer	1.01e-05	8.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GOT1—liver cancer	1.01e-05	8.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—liver cancer	9.92e-06	8.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMOX1—liver cancer	9.78e-06	8.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A1—liver cancer	9.68e-06	8.49e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—liver cancer	9.17e-06	8.05e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—liver cancer	9.12e-06	8e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—liver cancer	9.11e-06	7.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—liver cancer	9.04e-06	7.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—liver cancer	9.02e-06	7.92e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMOX1—liver cancer	9e-06	7.89e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CB—liver cancer	8.99e-06	7.89e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMOX1—liver cancer	8.92e-06	7.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HPGDS—liver cancer	8.87e-06	7.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARA—liver cancer	8.85e-06	7.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A1—liver cancer	8.64e-06	7.58e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—liver cancer	8.38e-06	7.35e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—liver cancer	8.31e-06	7.29e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—liver cancer	8.22e-06	7.21e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—liver cancer	8.06e-06	7.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.95e-06	6.98e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A1—liver cancer	7.95e-06	6.97e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMD10—liver cancer	7.91e-06	6.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMA4—liver cancer	7.91e-06	6.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARA—liver cancer	7.9e-06	6.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A1—liver cancer	7.88e-06	6.91e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—liver cancer	7.83e-06	6.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GOT2—liver cancer	7.69e-06	6.75e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—liver cancer	7.58e-06	6.65e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—liver cancer	7.49e-06	6.57e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—liver cancer	7.41e-06	6.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—liver cancer	7.34e-06	6.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—liver cancer	7.32e-06	6.42e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARA—liver cancer	7.27e-06	6.38e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2E1—liver cancer	7.23e-06	6.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARA—liver cancer	7.21e-06	6.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.1e-06	6.23e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—liver cancer	6.77e-06	5.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYCS—liver cancer	6.77e-06	5.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CD—liver cancer	6.67e-06	5.85e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GOT1—liver cancer	6.64e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GGT1—liver cancer	6.64e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—liver cancer	6.58e-06	5.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—liver cancer	6.53e-06	5.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.47e-06	5.68e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—liver cancer	6.39e-06	5.61e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—liver cancer	6.22e-06	5.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—liver cancer	6.17e-06	5.41e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—liver cancer	6.16e-06	5.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—liver cancer	6.01e-06	5.27e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—liver cancer	5.96e-06	5.23e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—liver cancer	5.96e-06	5.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CD—liver cancer	5.95e-06	5.22e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMOX1—liver cancer	5.88e-06	5.16e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—liver cancer	5.87e-06	5.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CB—liver cancer	5.81e-06	5.1e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—liver cancer	5.48e-06	4.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—liver cancer	5.48e-06	4.81e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CD—liver cancer	5.47e-06	4.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CD—liver cancer	5.42e-06	4.76e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—liver cancer	5.4e-06	4.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—liver cancer	5.36e-06	4.7e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A1—liver cancer	5.2e-06	4.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CB—liver cancer	5.19e-06	4.55e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—liver cancer	5.04e-06	4.42e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—liver cancer	4.84e-06	4.25e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CB—liver cancer	4.77e-06	4.18e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARA—liver cancer	4.75e-06	4.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CB—liver cancer	4.73e-06	4.15e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—liver cancer	4.48e-06	3.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—liver cancer	4.07e-06	3.57e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—liver cancer	3.93e-06	3.45e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CD—liver cancer	3.58e-06	3.14e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—liver cancer	3.54e-06	3.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—liver cancer	3.53e-06	3.1e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—liver cancer	3.16e-06	2.77e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CB—liver cancer	3.12e-06	2.74e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—liver cancer	2.91e-06	2.55e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—liver cancer	2.89e-06	2.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—liver cancer	2.88e-06	2.53e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—liver cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—liver cancer	2.38e-06	2.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—liver cancer	2.35e-06	2.07e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—liver cancer	1.9e-06	1.67e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—liver cancer	1.55e-06	1.36e-05	CbGpPWpGaD
